Century Therapeutics, Inc.
SEC CIK 1850119 · IPSC · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Pfeiffenberger Brent | Director · President and CEO | filed 2023 - 2026 |
| Quimi Daphne | Director | filed 2022 - 2026 |
| Blackwell Kimberly | Director | filed 2021 - 2026 |
| Riva Alessandro | Director | filed 2021 - 2026 |
| Lee Han Myung | Director | filed 2025 - 2026 |
| Murphy Martin Patrick | Director | filed 2026 - 2026 |
| Jimenez Joseph | Director | filed 2021 - 2025 |
| Butitta Cynthia M | Director | filed 2021 - 2025 |
| Walbert Timothy P | Director | filed 2022 - 2025 |
| Carlo Rizzuto | Director | filed 2021 - 2025 |
| Flores Osvaldo | Director · Chief Executive Officer | filed 2021 - 2023 |
| Casdin Eli | Director | filed 2021 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Carr Douglas | VP of Finance and Operations | filed 2021 - 2026 |
| Russotti Gregory | See Remarks | filed 2021 - 2026 |
| Cowan Chad | Chief Scientific Officer | filed 2024 - 2026 |
| Farid Adrienne | Chief Operations Officer | filed 2021 - 2025 |
| Conn Morgan | Chief Finanical Officer | filed 2024 - 2025 |
| Levitsky Hyam | President of R&D | filed 2021 - 2024 |
| Diem Michael Craig | Chief Financial Officer | filed 2021 - 2023 |
| Borges Luis | Chief Scientific Officer | filed 2021 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.